Endorectal magnetic resonance imaging for predicting pathologic T3 disease in Gleason score 7 prostate cancer: Implications for prostate brachytherapy
- 7 June 2012
- journal article
- research article
- Published by Elsevier BV in Brachytherapy
- Vol. 12 (3), 204-209
- https://doi.org/10.1016/j.brachy.2011.12.013
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (CA016672)
This publication has 41 references indexed in Scilit:
- MRI of the prostate: Interobserver agreement compared with histopathologic outcome after radical prostatectomyEuropean Journal of Radiology, 2012
- Predicting Post–External Beam Radiation Therapy PSA Relapse of Prostate Cancer Using Pretreatment MRIInternational Journal of Radiation Oncology*Biology*Physics, 2010
- Endorectal magnetic resonance imaging has limited clinical ability to preoperatively predict pT3 prostate cancerBJU International, 2010
- Development and internal validation of a nomogram predicting extracapsular extension in radical prostatectomy specimensInternational Journal of Urology, 2010
- The Role of Endorectal Magnetic Resonance Imaging in Predicting Extraprostatic Extension and Seminal Vesicle Invasion in Clinically Localized Prostate CancerKorean Journal of Urology, 2010
- Clinical Stage T1c Prostate Cancer: Evaluation with Endorectal MR Imaging and MR Spectroscopic ImagingRadiology, 2009
- Prediction of extraprostatic extension by prostate specific antigen velocity, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancerInternational Journal of Urology, 2008
- Incremental Value of Multiplanar Cross-Referencing for Prostate Cancer Staging with Endorectal MRIAmerican Journal of Roentgenology, 2007
- The radial distance of extraprostatic extension of prostate carcinomaCancer, 1999
- Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology.American Journal of Roentgenology, 1996